Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 8 Top Countries Contributing to Clinical Trials in Europe 9 Top Countries Contributing to Clinical Trials in North America 10 Clinical Trials by G7 Countries: Proportion of Diabetes Insipidus to Metabolic Disorders Clinical Trials 11 Clinical Trials by Phase in G7 Countries 12 Clinical Trials in G7 Countries by Trial Status 13 Clinical Trials by E7 Countries: Proportion of Diabetes Insipidus to Metabolic Disorders Clinical Trials 14 Clinical Trials by Phase 15 In Progress Trials by Phase 16 Clinical Trials by Trial Status 17 Clinical Trials by End Point Status 18 Subjects Recruited Over a Period of Time 19 Clinical Trials by Sponsor Type 20 Prominent Sponsors 21 Top Companies Participating in Diabetes Insipidus Therapeutics Clinical Trials 22 Prominent Drugs 23 Clinical Trial Profile Snapshots 24 Appendix 35 Abbreviations 35 Definitions 35 Research Methodology 36 Secondary Research 36 About GlobalData 37 Contact Us 37 Disclaimer 37 Source 38

List of Tables Diabetes Insipidus Therapeutics, Global, Clinical Trials by Region, 2016* 5 Diabetes Insipidus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Diabetes Insipidus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Diabetes Insipidus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8 Diabetes Insipidus Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9 Diabetes Insipidus Therapeutics Clinical Trials, North America, Top Countries, 2016* 10 Proportion of Diabetes Insipidus to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 11 Diabetes Insipidus Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12 Diabetes Insipidus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13 Proportion of Diabetes Insipidus to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 14 Diabetes Insipidus Therapeutics, Global, Clinical Trials by Phase, 2016* 15 Diabetes Insipidus Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 16 Diabetes Insipidus Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17 Diabetes Insipidus Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18 Diabetes Insipidus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 19 Diabetes Insipidus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 20 Diabetes Insipidus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 21 Diabetes Insipidus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 22 Diabetes Insipidus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 23 List of Figures Diabetes Insipidus Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Diabetes Insipidus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Diabetes Insipidus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Diabetes Insipidus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8 Diabetes Insipidus Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9 Diabetes Insipidus Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10 Proportion of Diabetes Insipidus to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 11 Diabetes Insipidus Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12 Diabetes Insipidus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13 Proportion of Diabetes Insipidus to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 14 Diabetes Insipidus Therapeutics, Global, Clinical Trials by Phase (%), 2016* 15 Diabetes Insipidus Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 16 Diabetes Insipidus Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17 Diabetes Insipidus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 19 Diabetes Insipidus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 20 Diabetes Insipidus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 21 Diabetes Insipidus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 22 Diabetes Insipidus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 23 GlobalData Methodology 36

Teva Pharmaceutical Industries Ltd. SAVA Medica Limited MDS Pharma Services Inc Lipotec SA Ferring International Center S.A. Curatis AG